MedPath

Found 556472 clinical trials

Sort by:

External Trigeminal Nerve Stimulation for Children With ASD + ADHD to Reduce Elevated Symptoms

Not Applicable

Recruiting

Conditions: Attention Deficit Disorder With Hyperactivity (ADHD)
Autism Spectrum Disorder (ASD)

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 60

Registration Number: NCT07214545

Locations: 🇺🇸
UCSF Nancy Friend Pritzker Psychiatry Building, San Francisco, California, United States

A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours

Not Applicable

Not yet recruiting

Conditions: Locally Advanced Solid Tumor
Metastatic Solid Tumor

Interventions: Biological: IPN60300

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Ipsen

Target Recruit Count: 102

Registration Number: NCT07213817

Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse

Not Applicable

Not yet recruiting

Conditions: Opioid Use
Surgical Recovery
Vaginal Hysterectomy
Prolapse Pelvic
Postoperative Pain

Interventions: Drug: Bupivacaine-epinephrine
Drug: Normal saline

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 56

Registration Number: NCT07213635

Locations: 🇺🇸
University of North Carolina Urogynecology and Reconstructive Pelvic Surgery at REX, Raleigh, North Carolina, United States

Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking

Not Applicable

Not yet recruiting

Conditions: Alcohol Use Disorder

Interventions: Other: Placebo
Drug: Suvorexant 10 mg

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Ohio State University

Target Recruit Count: 250

Registration Number: NCT07214207

Planning Together: A Couple-based, Multi-level Prenatal Contraceptive Education Program for Economically Marginalized Families

Not Applicable

Not yet recruiting

Conditions: Short Interpregnancy Intervals
Maternal Health Disparities

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: University of Tennessee Graduate School of Medicine

Target Recruit Count: 60

Registration Number: NCT07214012

Locations: 🇺🇸
University of Tennessee Graduate School of Medicine, Knoxville, Tennessee, United States

A Clinical Study to Evaluate the Stain Reduction Efficacy of a Non-Fluoride Tooth Whitening Dentifrice Containing Nano-Hydroxyapatite (nHAP) and a High Cleaning Silica Abrasive System Compared to a Commercial Fluoride Non-Whitening Dentifrice as a Negative Control

Not Applicable

Active, not recruiting

Conditions: Teeth Color
Teeth Staining

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Boka LLC

Target Recruit Count: 120

Registration Number: NCT07214038

Locations: 🇮🇳
Global Health Research Group, New Delhi, National Capital Territory of Delhi, India

SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome

Not Applicable

Not yet recruiting

Conditions: Nephrotic Syndrome

Interventions: Drug: Dapagliflozin
Drug: Empagliflozin
Other: Standard Therapy

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Mansoura University

Target Recruit Count: 75

Registration Number: NCT07214818

Locations: 🇪🇬
Urology & Nephrology Center, Mansoura University, Al Mansurah, Dakahlia Governorate, Egypt

Follicular Fluid microRNAs in Ovarian Aging and Reproduction

Recruiting

Conditions: Ovarian Aging
In Vitro Fertilisation (IVF) Treatment
InVitro Fertilization
In Vitro Fertilization Outcome

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: University of Central Florida

Target Recruit Count: 100

Registration Number: NCT07214246

Locations: 🇺🇸
University of Central Florida, Orlando, Florida, United States

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Not Applicable

Not yet recruiting

Conditions: Breast Neoplasms
Carcinoma, Ductal, Breast
Receptors, Estrogen (for ER-positive Requirement)

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Natera, Inc.

Target Recruit Count: 725

Registration Number: NCT07214532

Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies

Not Applicable

Not yet recruiting

Conditions: Allogeneic Stem Cell Transplant Recipient

Interventions: Drug: Fludarabine
Radiation: Intermediate-dose Total Body Irradiation (TBI)
Drug: Post-transplant Cyclophosphamide (PTCy)
Drug: Tacrolimus
Drug: Mycophenolate mofetil (MMF)

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 209

Registration Number: NCT07214688

Locations: 🇺🇸
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington D.C., District of Columbia, United States
🇺🇸
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States
🇺🇸
John Theurer Cancer Center at Jersey Shore University Medical Center, Neptune City, New Jersey, United States

AI-Powered Research

Premium Access

External Trigeminal Nerve Stimulation for Children With ASD + ADHD to Reduce Elevated Symptoms

A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours

Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse

Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking

Planning Together: A Couple-based, Multi-level Prenatal Contraceptive Education Program for Economically Marginalized Families

A Clinical Study to Evaluate the Stain Reduction Efficacy of a Non-Fluoride Tooth Whitening Dentifrice Containing Nano-Hydroxyapatite (nHAP) and a High Cleaning Silica Abrasive System Compared to a Commercial Fluoride Non-Whitening Dentifrice as a Negative Control

SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome

Follicular Fluid microRNAs in Ovarian Aging and Reproduction

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies

Product

Company

Legal